NCT06411795View on ClinicalTrials.gov

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

PHASE2RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Duodenal NeoplasmPancreatic Neoplasm
Interventions
DRUG

Bupivacaine

Given via epidural and injection

DRUG

Hydromorphone

Given via epidural

DRUG

Iopamidol

Given via epidural

DRUG

Liposomal Bupivacaine

Given injection

OTHER

Medical Chart Review

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

DRUG

Thoracic Epidural Analgesia

Undergo thoracic epidural placement

PROCEDURE

Ultrasound Imaging

Undergo ultrasound

PROCEDURE

X-Ray Imaging

Undergo x-ray

Trial Locations (1)

55455

RECRUITING

University of Minnesota/Masonic Cancer Center, Minneapolis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Masonic Cancer Center, University of Minnesota

OTHER